Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer

NCT02593227 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: Low dose FRα vaccine
DRUG: Cyclophosphamide
BIOLOGICAL: High dose FRα vaccine

Sponsor

Marker Therapeutics, Inc.